Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for sedation during emergency procedures in young children
2017-000057-40Phase 2Terminated
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in None (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Pain during the procedure. Started Jan 2017; status: terminated.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on 2017-000057-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000057-40.